Komori
GNI Group (2160) · InitiativeFirst stated

Plan to Acquire Additional Gyre Pharmaceuticals Shares

First written in FY2025-H1. . Latest entry: FY2025-H1.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Increasing the stake through the additional acquisition of Gyre Pharmaceuticals sharesA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2025-H1First statedAnnual report

    「①非支配株主が保有するGyre Pharmaceuticalsの株式約30％（議決権ベース）のうち、約10％の取得対価として、2026年12月末までに4,859,040千円を充当する予定です。」

    海外募集による調達資金の使途として、非支配株主が保有するGyre Pharmaceuticals株式の約10％を2026年12月末までに取得する計画を新たに示した。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for GNI Group yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.